Leiden, The Netherlands, 23 December 2021 – Fibriant, a scale-up biotech company focused on
the development of the RECOFIB platform, was awarded up to € 16.5 million in funding of the
European Innovation Council Accelerator program
Fibriant awarded Euro 16.5M EIC Accelerator funding to support RECOFIB development
Comments are closed.